Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Geelong
Clinical trial register · Australia

Clinical Trials in Geelong, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company10 GlaxoSmithKline5 Hoffmann-La Roche4 Pfizer4 Regeneron Pharmaceuticals3
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Geelong

74 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
A Study of a Device That Helps Place Dialysis Needles
NCT07856095Dialysis, Cannulation, Vascular Access
X9, Inc.
Not applicable
35
Geelong, Melbourne
2026-12
Recruiting
Eli Lilly and Company
Phase 3
1,000
Brisbane, Bruce, Carlton, Elizabeth Vale, Geelong, Melbourne, Toowoomba, Westmead
2026-08-14
Recruiting
BeOne Medicines
Phase 1
118
Concord, Kogarah, Kurralta Park, Geelong, Heidelberg, Nedlands
2026-06-23
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Blacktown, Macquarie Park, Clayton, Geelong, Melbourne, St Albans, Perth
2026-05-21
Recruiting
Eli Lilly and Company
Phase 3
900
Botany, Box Hill, Brisbane, Camberwell, Geelong, Heidelberg West, Merewether, Oaklands Park
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
1,000
Carlton, Elizabeth Vale, Geelong, Melbourne, Toowoomba, Westmead
2026-02-09
Recruiting
European Myeloma Network B.V.
Phase 3
1,000
Adelaide, Box Hill, Canberra, Geelong, Heidelberg, Kingswood, Melbourne, Sunshine Coast
2025-12-23
Recruiting
GlaxoSmithKline
Phase 1
83
Douglas, Tugun, Geelong, Bendigo
2025-12-03
Recruiting
AbbVie
Phase 2
400
Kogarah, Sydney, Auchenflower, Adelaide, Hobart, Clayton, Geelong, Melbourne
2025-11-13
Recruiting
Kivu Bioscience Inc.
Phase 1
76
Camperdown, Sydney, Brisbane, Adelaide, Geelong
2025-11-13
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Sydney, Waratah, South Brisbane, Adelaide, Clayton, Geelong, Heidelberg, Nedlands
2025-11-03
Recruiting
Eli Lilly and Company
Phase 3
1,205
Box Hill, Brisbane, Canberra, Geelong, Meadowbrook, Perth, Southport, St Leonards
2025-10-31
Recruiting
Eli Lilly and Company
Phase 3
4,500
Adelaide, Box Hill, Brisbane, Broadmeadow, Geelong, Heidelberg, Ipswich, Murdoch
2025-10-15
Recruiting
Center for Eye Research Australia
Phase 4
144
East Melbourne, Geelong
2025-09-19
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Adelaide, Box Hill, Brisbane, Burwood, Clayton, Frankston, Geelong, Greenfields
2025-09-02
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Darlinghurst, Gateshead, North Sydney, Wahroonga, Clayton, Geelong, Melbourne, Saint Albans
2025-08-26
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Sydney, Warrawong, Brisbane, Douglas, Southport, Box Hill, Geelong, Parkville
2025-06-19
Active, closed
Boehringer Ingelheim
Phase 1
91
Gosford, Geelong
2025-05-14
Recruiting
BioNTech SE
Phase 1/2
594
Camperdown, Bedford Park, Bendigo, Geelong, Saint Albans, Subiaco
2025-05-02
Recruiting
AstraZeneca
Phase 3
11,300
Adelaide, Castle Hill, Coffs Harbour, Elizabeth Vale, Fremantle, Geelong, Kingswood, Leabrook
2025-03-14
Recruiting
Silexan in the Treatment Of Posttraumatic Stress Disorder Trial
NCT06412757Post Traumatic Stress Disorder
Deakin University
Phase 3
278
Carlton, Geelong, Heidelberg, Melbourne
2024-08-26
Active, closed
GlaxoSmithKline
Phase 3
10,212
Botany, Coffs Harbour, Sydney, Taringa, Tarragindi, Camberwell, Geelong, Spearwood
2024-08-01
Recruiting
Barwon Health
Phase 2
200
Geelong, Melbourne
2024-07-09
Recruiting
National Robotics-Assisted Radical Prostatectomy Database
NCT06279260Database, Prostate Cancer, Robotic-assisted Radical Prostatectomy, Surgical Outcomes
Melbourne Health
Observational
10,000
Ballarat, Geelong, Melbourne
2024-07-01
Active, closed
Eli Lilly and Company
Phase 3
10,000
Adelaide, Botany, Box Hill, Brisbane, Brookvale, Camberwell, Garran, Geelong
2024-04-30
Recruiting
AstraZeneca
Phase 3
3,850
Blacktown, Cairns, Canberra, Chermside, Clayton, Concord, Frankston, Geelong
2024-04-12
Recruiting
GlaxoSmithKline
Phase 3
864
Blacktown, Douglas, Herston, Ballarat, Geelong, Melbourne
2024-03-21
Recruiting
Pfizer
Phase 3
492
Blacktown, Concord, Birtinya, Brisbane, Fitzroy, Geelong, Nedlands
2024-02-08
Active, closed
BicycleTx Limited
Phase 2
375
Adelaide, Brisbane, Douglas, Geelong, Hunter, Nedlands, New South Wales, South Brisbane
2024-01-24
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Frenchs Forest, Kingswood, North Sydney, Buderim, South Brisbane, Adelaide, Geelong, St Albans
2023-12-11
Active, closed
Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
NCT05788081Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV
DrugsGolcadomide·Opdivo·Rituximab·Nivolumab
Olivia Newton-John Cancer Research Institute
Phase 2
40
Ballarat, Box Hill, Geelong, Heidelberg, Perth
2023-08-31
Active, closed
Pfizer
Phase 3
59
Adelaide, Geelong
2023-08-09
Active, closed
OM Pharma SA
Phase 2
296
Geelong, Melbourne
2023-06-20
Recruiting
The Bionics Institute of Australia
Not applicable
40
East Melbourne, Fitzroy, Geelong, Moonee Ponds, Parkville
2023-05-02
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Camperdown, Kingswood, Wollongong, Bedford Park, Darlinghurst, Bendigo, Frankston, Geelong
2023-04-30
Active, closed
Bayer
Phase 3
985
Camperdown, Epping, Liverpool, Wahroonga, Adelaide, Box Hill, East Melbourne, Geelong
2023-04-03
Active, closed
ICM Co. Ltd.
Observational
10
Adelaide, Geelong
2023-03-16
Active, closed
Pfizer
Phase 3
624
Coffs Harbour, Birtinya, Woolloongabba, Kurralta Park, Hobart, Brighton, Geelong, Malvern
2023-03-03
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Blacktown, Lismore, Liverpool, Wollstonecraft, Bedford Park, North Adelaide, Box Hill, Geelong
2023-01-16
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Camperdown, Geelong, Liverpool, Nedlands, New South Wales, Wollongong, Woolloongabba
2022-10-25
Active, closed
Eli Lilly and Company
Phase 3
15,374
Adelaide, Blacktown, Box Hill, Brisbane, Camberwell, Clayton, Deakin, Geelong
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ballarat Central, Box Hill, Clayton, Coffs Harbour, Darlinghurst, Geelong, Hobart, Launceston
2022-10-04
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Adelaide, Birtinya, Douglas, Geelong, Melbourne, Newcastle, Sydney
2022-09-08
Active, closed
GlaxoSmithKline
Phase 3
3,038
Warrawong, Westmead, Geelong
2022-08-10
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Southport, Townsville, North Adelaide, Hobart, Geelong, Melbourne
2022-07-14
Recruiting
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
NCT04876131Complicated Urinary Tract Infection, Infection, Pediatric Infectious Disease
Murdoch Childrens Research Institute
Phase 4
396
Adelaide, Geelong, Melbourne, Parkville, Perth
2022-05-30
Recruiting
AbbVie
Phase 3
768
Port Macquarie, Westmead, Geelong, Heidelberg
2022-03-25
Active, closed
Australasian Gastro-Intestinal Trials Group
Not applicable
6
Albury, Bendigo, Box Hill, Epping, Fitzroy, Geelong, Melbourne, Saint Albans
2021-12-14
Active, closed
Olema Pharmaceuticals, Inc.
Phase 1
60
Waratah, Westmead, South Brisbane, Southport, Clayton, Frankston, Geelong, Nedlands
2021-12-10
Active, closed
Hoffmann-La Roche
Phase 3
478
Waratah, Woolloongabba, Adelaide, Geelong
2021-10-27
Active, closed
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
NCT04829604HER2 Positive Metastatic Breast Cancer
DrugARX788
Ambrx, Inc.
Phase 2
72
Frankston, Geelong, Nedlands
2021-10-26
Recruiting
Pfizer
Phase 3
893
Benowa, Clayfield, Greenslopes, Woolloongabba, East Melbourne, Fitzroy, Geelong, Melbourne
2021-10-04
Active, closed
Bristol-Myers Squibb
Phase 3
338
Botany, Parramatta, Maroochydore, Woodville South, Camberwell, Geelong, Ivanhoe
2021-09-15
Recruiting
Australian and New Zealand Intensive Care Research Centre
Phase 2
450
Sydney, Wollongong, Birtinya, Brisbane, Southport, Adelaide, Geelong, Melbourne
2021-07-15
Active, closed
Bristol-Myers Squibb
Phase 3
729
Botany, Parramatta, Maroochydore, Woodville, Camberwell, Geelong
2021-07-15
Active, closed
Incyte Corporation
Phase 3
899
Adelaide, Ballarat, Birtinya, Brisbane, Canberra, Clayton, Frankston, Geelong
2021-05-11
Recruiting
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
NCT04502394Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
DrugsNavtemadlin·Acalabrutinib
Kartos Therapeutics, Inc.
Phase 1/2
84
Adelaide, Box Hill, Geelong, Perth
2021-02-23
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Kogarah, Bedford Park, Geelong, Melbourne
2020-11-25
Active, closed
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
NCT04452591Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer
DrugCretostimogene Grenadenorepvec
CG Oncology, Inc.
Phase 3
190
Miranda, Geelong, Melbourne
2020-10-27
Active, closed
Hoffmann-La Roche
Phase 1/2
210
Geelong, St Albans
2020-09-03
Recruiting
Takeda
Phase 2
160
Albury, Tweed Heads, Westmead, Douglas, Adelaide, Bedford Park, Box Hill, Geelong
2020-08-19
Active, closed
Epizyme, Inc.
Phase 3
599
Adelaide, Bedford Park, Clayton, Geelong, Nedlands, Frankston, Hobart, Southport
2020-06-11
Active, closed
GlaxoSmithKline
Phase 3
325
Gosford NSW, Liverpool, St Leonards, Woodville, Hobart, Clayton, Fitzroy, Geelong
2020-04-02
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Adelaide, Brisbane, Camperdown, Douglas, Geelong, Gosford, Hobart, Melbourne
2019-12-20
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
East Albury, Tweed Heads, East Melbourne, Frankston, Geelong, Heidelberg, Perth
2019-11-13
Active, closed
Applied Therapeutics, Inc.
Phase 3
675
Chermside, Milton, Taringa, Hobart, Geelong, Heidelberg, Melbourne
2019-09-20
By invitation
University of Edinburgh
Observational
287
Geelong, Nedlands, Newcastle, Sydney, Toowoomba
2019-04-05
Recruiting
Imugene Limited
Phase 1
135
Camperdown, Liverpool, Adelaide, Fitzroy, Geelong
2019-03-11
Active, closed
ERG Components in Schizophrenia and Bipolar Disorder Type I
NCT03788811Schizophrenia, Bipolar I Disorder
diaMentis Inc.
Observational
300
Clayton, Geelong, Melbourne
2018-07-05
Active, closed
Acerta Pharma BV
Phase 3
310
Adelaide, Box Hill, Frankston, Geelong, Gosford, Hobart, Kogarah, Murdoch
2017-02-02
Recruiting
University of Texas Southwestern Medical Center
Phase 3
272
Fitzroy, Geelong
2015-07
Active, closed
Acerta Pharma BV
Phase 3
535
Darlinghurst, Frankston, Geelong, South Brisbane, Waratah NSW, Wollongong, Woodville
2015-06-26
Active, closed
Eli Lilly and Company
Phase 3
493
Camperdown, Sydney, Wahroonga, South Brisbane, Woolloongabba, Woodville, Geelong, Murdoch
2014-11-06
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Adelaide, Box Hill, Camperdown, Darlinghurst, Geelong, Gosford, Hobart, Kogarah
2013-10-14
Rows per page Showing 1–74 of 74
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/geelong

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 74 of those studies with a site in Geelong.

How many clinical trials are recruiting in Geelong?

36 of the 74 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 36 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Geelong), 74 studies
PhaseStudiesRecruitingShare
Phase 3431958.1%
Phase 210513.5%
Phase 1648.1%
Not applicable425.4%
Observational415.4%
Phase 1/2425.4%
Phase 4222.7%
Phase 2/3111.4%

Most active sponsors

Lead sponsors with the most studies (Geelong)
Lead sponsorStudiesRecruiting
Eli Lilly and Company106
GlaxoSmithKline52
Hoffmann-La Roche41
Pfizer42
Regeneron Pharmaceuticals30
AbbVie22
Acerta Pharma BV20
AstraZeneca22
Bristol-Myers Squibb20
European Myeloma Network B.V.22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.